U.S. National Institute of Health www.cancer.gov National Cancer Institute
National Cancer Institute
NCI Alliance for Nanotechnology in Cancer

Skip Header Links
About Programs News Resources Events Intranet Login
National Cancer Institute


NCI Alliance for
Nanotechnology in Cancer


Programs

Centers of Cancer Nanotechnology Excellence (CCNEs)

 

  Projects

  Cores

  Investigators

Platform Partnerships
Multidisciplinary
Research Training
and Team Development
Nanotechnology Characterization Laboratory (NCL)

 

MIT-Harvard Center of Cancer Nanotechnology
Massachusetts Institute of Technology and Harvard University CCNE

Center Investigators

Robert Langer, Ph.D.
Principal Investigator

Ralph Weissleder, M.D., Ph.D.
Principal Investigator

Publications

Nanomedicine: Developing smarter therapeutic and diagnostic modalities.
Farokhzad and Langer.
Adv Drug Deliv Rev. 2006 Oct 27; [Epub ahead of print].

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
Cheng et al.
Biomaterials. 2006 Oct 19; [Epub ahead of print].

Drug delivery systems in urology—getting "smarter”
Farokhzad et al.
Urology. 2006 Sep;68(3):463-9.

An x-ray imaging agent based on long circulating bismuth sulfide nanoparticles.
Rabin O, Perez JM, Grimm J, Wojtkiewicz G, Weissleder R.
Nature Materials, 2006;5(2):118-122.

Continuous Analyte Sensing with Magnetic Nanoswitches.
Sun EY, Weissleder R, Josephson L.
Small, 2006;2 (10): 1144-1147.

 


A Service of the National Cancer Institute
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov Nanotechnology Characterization Lab Nanotechnology Teaming Portal